Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 3, 2000, Pages 635-642

  Storey, Mark R ^a   Pollack, Alan ^a,b   Zagars, Gunar ^a   Smith, Lewis ^a   Antolak, John ^a   Rosen, Isaac ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Dept of Radiation Oncology ^*  (United States)

Author keywords

Dose escalation; Prostate cancer; Radiotherapy; Rectal complications

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER DISEASE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; RECTUM;

AGED; HUMANS; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECTUM; URINARY BLADDER;

EID: 0034307033     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00700-8     Document Type: Article

References (20)

1. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer A randomized trial . Lancet. 353:(9149):1999;267-272.
2. Soffen E.M., Hanks G.E., Hunt M.A., et al. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques A reduction in acute morbidity . Int J Radiat Oncol Biol Phys. 24:1992;485-488.
3. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone . Int J Radiat Oncol Biol Phys. 32:1995;3-12.
4. Lee W.L., Hanks G.E., Hanlon A.L., et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer Further evidence for a significant dose effect . Int J Radiat Oncol Biol Phys. 35:1996;251-257.
5. Zelefsky M.J., Fuks Z., Wolfe T., et al. Locally advanced prostatic cancer Long term toxicity outcome after three-dimensional conformal radiation therapy - A dose-escalation study . Radiology. 209:1998;169-174.
6. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
7. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
8. Pavy J.J., Denekamp J., Letschert J., et al. Late effects toxicity scoring The SOMA scale . Int J Radiat Oncol Biol Phys. 31:1995;1043-1049.
9. Hanlon A.L., Schultheiss T.E., Hunt M.A., et al. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
10. Altman D.G. Practical statistics for medical research. 1991;Chapman and Hall, London. p. 179-268.
11. Harris E.K., Albert A. Survivorship analysis for clinical studies. 1991;Marcel Dekker, Inc, New York. p. 5-125.
12. Pilepich M.V., Krall J.M., Sause W.T., et al. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate - Analysis of RTOG protocol study 75-06. Int J Radiat Oncol Biol Phys. 13:1987;351-357.
13. Hanks G.E., Diamond J.J., Krall J.M., et al. A ten year followup of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys. 13:1987;499-505.
14. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
15. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
16. Pollack A, Smith LG, Von Eschenbach AC. External beam radiotherapy dose-response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 2000;48:507-512.
17. Benk V.A., Adams J.A., Shipley W.U., et al. Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys. 26:1993;551-557.
18. Hartford A.C., Nienierko A., Adams J.A., et al. Conformal irradiation of the prostate estimating long-term rectal bleeding risk using dose-volume histograms . Int J Radiat Oncol Biol Phys. 36:1996;721-730.
19. Zelfsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468.
20. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.